The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and of the Federal Food, Drug, and Cosmetic Act (FDCA).* fda warning bpc 157 peptide products New Details 157 FDA Moves on Peptides: What Compounding Pharmacies Need to Know FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies Wave of FDA Warning Letters to Injectable Compounders in Q1 2014 Follows 2013 Inspection Blitz and Legislative Empowerment; Reci